Status:
RECRUITING
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Lead Sponsor:
Prostate Cancer Clinical Trials Consortium
Conditions:
Prostate Cancer
Eligibility:
MALE
21+ years
Brief Summary
Our intent is to establish the International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) as a prospective, international cohort of minimum 5,000 men with advanced cance...
Eligibility Criteria
Inclusion
- • Willing and able to provide written informed consent and privacy authorization for the release of personal health information.
- NOTE: Privacy authorization may be either included in the informed consent or obtained separately.
- Males 21 years of age and above
- Histological or cytological confirmed prostate adenocarcinoma from TRUS biopsy, radical prostatectomy or TURP Or Documented histopathology or cytopathology of prostate adenocarcinoma from a biopsy of a metastatic site Or Metastatic disease typical of prostate cancer (i.e., involving bone or pelvic lymph nodes or para-aortic lymph nodes) AND a serum concentration of PSA \>20ng/mL at the time of initial prostate cancer diagnosis
- No previous diagnosis of a second, non-prostate malignancy that requires additional systemic therapy except cancer in situ of bladder and basal cell cancer of skin
Exclusion
Key Trial Info
Start Date :
July 21 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2032
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT03151629
Start Date
July 21 2017
End Date
January 1 2032
Last Update
January 6 2026
Active Locations (121)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama-Birmingham
Birmingham, Alabama, United States, 35233
2
University of Alabama- Tuscaloosa
Tuscaloosa, Alabama, United States, 35487
3
University of California - Los Angeles
Los Angeles, California, United States, 90024
4
University of California San Diego
San Diego, California, United States, 92037